Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177567 · ClinicalTrials.gov registry record · Phase 4
Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
A Phase 4 study of Bipolar Disorder, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT00177567 is a Phase 4 study of Bipolar Disorder that has completed, run by University of Pittsburgh. The registered enrollment target is 60 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00177567, a Phase 4 study of Bipolar Disorder, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to collect pilot data on the feasibility of recruiting, eliciting informed consent, assessing, treating, and following patients aged 60 and older with bipolar mood disorders.
Conditions Studied
Interventions
- DRUG risperidone
- DRUG lithium carbonate
- DRUG Depakote-ER
- DRUG olanzapine
- DRUG paroxetine
Study Locations (2)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
- University of Pittsubrgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2001-07 |
| Est. Completion | 2004-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00177567
The ClinicalTrials.gov registry entry for NCT00177567 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (82% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 5 interventions - of which risperidone is the first listed.
NCT00177567 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00177567 about?
NCT00177567 is a clinical study titled "Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study". The purpose of this study is to collect pilot data on the feasibility of recruiting, eliciting informed consent, assessing, treating, and following patients aged 60 and older with bipolar mood disorders.
What is the current status of trial NCT00177567?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2001-07. Estimated completion is 2004-01.
What conditions does trial NCT00177567 study?
This clinical trial studies the following conditions: Bipolar Disorder.
What interventions are being tested in trial NCT00177567?
The interventions under investigation include: risperidone (DRUG), lithium carbonate (DRUG), Depakote-ER (DRUG), olanzapine (DRUG), paroxetine (DRUG).
Who is sponsoring clinical trial NCT00177567?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00177567 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
-
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
COMPLETED · Phase 4
-
Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
COMPLETED · Phase 4
-
Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
COMPLETED · Phase 4
-
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
COMPLETED · Phase 4
-
Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.